ODN 1826

[1]Hou Y, et al. Lipoamide Ameliorates Oxidative Stress via Induction of Nrf2/ARE Signaling Pathway in PC12 Cells. J Agric Food Chem. 2019 Jul 24;67 (29) :8227-8234.|[2]Qi XF, et al. CpG oligodeoxynucleotide induces apoptosis and cell cycle arrest in A20 lymphoma cells via TLR9-mediated pathways. Mol Immunol. 2013 Jul;54 (3-4) :327-37. |[3]Utaisincharoen P, et al. CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7) . Clin Exp Immunol. 2002 Jun;128 (3) :467-73.|[4]Jordan M, et al. CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model. Cancer Lett. 2016 Apr 1;373 (1) :88-96.|[5]Krogmann AO, et al. Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice. PLoS One. 2016 Jan 11;11 (1) :e0146326. |[6]Yuan S, et al. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor. Cancer Biother Radiopharm. 2011 Apr;26 (2) :203-8.

ACS Appl Mater Interfaces. 2024 Jul 31;16 (30) :39153-39164.|Adv Mater. 2025 Sep 1:e02375.|Biochem Biophys Res Commun. 2024 Apr 16:704:149661.|Hepatology. 2025 Nov 7.|Life Sci. 2025 Aug 29:380:123930.|Nano Today. 2025 Oct.|Neurochem Res. 2025 Sep 5;50 (5) :288.|Research Square Preprint. 2024 Dec 18.